J. Keith Joung

J. Keith Joung is a leading innovator in the field of genome editing. He currently serves as Associate Chief of Pathology for Research and The Jim and Ann Orr Research Scholar at Massachusetts General Hospital (MGH) and is Professor of Pathology at Harvard Medical School. He is also a member of the Center for Cancer Research and the Center for Computational and Integrative Biology at MGH. Dr. Joung has been a pioneer in the development of important technologies for targeted genome editing and epigenome editing of human cells. He has received numerous awards including an NIH Director's Pioneer Award, an NIH Director's Transformative Research Project R01 Award, the Jim and Ann Orr MGH Research Scholar Award, and election into the American Association of University Pathologists. He serves on the Scientific Advisory Boards of the Keystone Symposia, Horizon Discovery, and Transposagen Biopharmaceuticals. He is also a scientific co-founder of Editas Medicine, a company dedicated to the translation of genome editing technologies for therapy of human diseases. Dr. Joung holds a Ph.D. in genetics from Harvard University, an M.D. from Harvard Medical School and an A.B. in biochemical sciences from Harvard College.